Two families with TET3-related disorder showing neurodevelopmental delay with craniofacial dysmorphisms
- PMID: 34719681
- DOI: 10.1038/s10038-021-00986-y
Two families with TET3-related disorder showing neurodevelopmental delay with craniofacial dysmorphisms
Abstract
TET3 at 2p13.1 encodes tet methylcytosine dioxygenase 3, a demethylation enzyme that converts 5-methylcytosine to 5-hydroxymethylcytosine. Beck et al. reported that patients with TET3 abnormalities in either an autosomal dominant or recessive inheritance fashion clinically showed global developmental delay, intellectual disability, and dysmorphisms. In this study, exome sequencing identified both mono- and biallelic TET3 variants in two families: a de novo variant NM_001287491.1:c.3028 A > G:p.(Asn1010Asp), and compound heterozygous variants NM_001287491.1:c.[2077 C > T];[2896 T > G],p.[Gln693*];[Cys966Gly]. Despite the different inheritance modes, the affected individuals showed similar phenotypic features. Including these three patients, only 14 affected individuals have been reported to date. The accumulation of data regarding individuals with TET3-related disorder is necessary to describe their clinical spectrum.
© 2021. The Author(s), under exclusive licence to The Japan Society of Human Genetics.
References
-
- Wu X, Zhang Y. TET-mediated active DNA demethylation: mechanism, function and beyond. Nat Rev Genet. 2017;18:517–34. - DOI
-
- Leturcq M, Lefebvre T, Vercoutter-Edouart AS. O-GlcNAcylation and chromatin remodeling in mammals: An up-to-date overview. Biochem Soc Trans. 2017;45:323–38. - DOI
-
- Konzman D, Abramowitz LK, Steenackers A, Mukherjee MM, Na HJ, Hanover JA. O-GlcNAc: regulator of signaling and epigenetics linked to X-linked intellectual disability. Front Genet. 2020;11:1–19. - DOI
-
- Kizuka Y, Kitazume S, Okahara K, Villagra A, Sotomayor EM, Taniguchi N. Epigenetic regulation of a brain-specific glycosyltransferase N-acetylglucosaminyltransferase-IX (GnT-IX) by specific chromatin modifiers. J Biol Chem. 2014;289:11253–61. - DOI
-
- Deplus R, Delatte B, Schwinn MK, Defrance M, Méndez J, Murphy N, et al. TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS. EMBO J. 2013;32:645–55. - DOI
MeSH terms
Substances
Grants and funding
- JP21ek0109486/Japan Agency for Medical Research and Development (AMED)
- JP21ek0109549/Japan Agency for Medical Research and Development (AMED)
- JP21cm0106503/Japan Agency for Medical Research and Development (AMED)
- JP21ek0109493/Japan Agency for Medical Research and Development (AMED)
- JP20K07907/MEXT | Japan Society for the Promotion of Science (JSPS)
LinkOut - more resources
Medical